About
Dr Juliana Chaves is currently a Research Officer with White’s Group. Her research focuses on developing an in vitro model of the Blood-Brain Barrier (BBB) using hiPSC-derived cells. She investigates the mechanisms underlying neurodegenerative diseases such as Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), Childhood dementia, among others, aiming to enhance drug delivery to the brain. Her work involves modulating BBB transporters through Focused Ultrasound (FUS) treatments and other innovative methods. Dr Chaves completed her Biomedical Science degree at Universidade Cidade de São Paulo (UNICID) from 2012 to 2016, followed by a First-Class Honours Degree in Neurobiology and Neuroscience from the University of São Paulo (USP) between 2013 and 2015. She earned her PhD in Neuroscience from Queensland University of Technology (QUT) from 2020 to 2024, where she was awarded the QUT Postgraduate Research Award (QUTPRA) for International Students. Her research has resulted in over 10 publications in peer-reviewed and high-impact journals, significantly contributing to her field.